Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: The Multicenter, Open-label, Single-use Autoinjector Convenience Study [Phase 3]
Phase 3 multicenter open-label study assessing autoinjector convenience for an MS therapy; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study [Phase 3]
This Phase 3 multicenter, open-label study evaluated the ease of use of the RebiSmart autoinjector in multiple sclerosis patients; results w…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study [Phase 3]
Phase 3 BENEFIT trial and its follow-up in newly diagnosed multiple sclerosis completed; results were posted on 2010-11-30 evaluating interf…
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of MLN1202 in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis. [Phase 3]
Completed Phase 3 trial evaluating the suitability of the RebiSmart auto-injector for self-injection in relapsing multiple sclerosis patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS) [NA]
A completed clinical trial examined the effects of Vitamin D3 supplementation on T cell compartments in individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating Rebif New Formulation (RNF) for relapsing forms of multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2010-07-01Clinical Trial Update: Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus [Phase 2]
Open-label Phase 2 extension study evaluating Neramexane for congenital and acquired nystagmus has been terminated. The update summarizes sa…
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
Completed open-label tolerability and safety monitoring study of Novantrone (mitoxantrone) in a selected cohort of patients with multiple sc…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Rebif® Pregnancy Registry
The Rebif pregnancy registry for multiple sclerosis has completed. Results were posted on 2010-06-02.
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: FolateScan in Autoimmune Disease [Phase 2]
A Phase 2 clinical trial of FolateScan in autoimmune diseases has completed, including rheumatoid arthritis, osteoarthritis, multiple sclero…
-
CLINICAL_TRIALS trial_result · 2010-03-08Clinical Trial Update: Avonex 15 Year Long Term Follow-up Study
This document provides a long-term (15-year) follow-up update for Avonex (interferon beta-1a) in multiple sclerosis, with the trial status l…
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
A completed clinical trial evaluating ATP expression in lymphocytes of individuals with multiple sclerosis using the ImmuKnow assay.
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis [Phase 3]
An open-label Phase 3 study evaluating the effect, safety and tolerability of Betaferon 250 µg in Chinese-origin patients with multiple scle…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) [Phase 4]
Phase 4 clinical trial evaluating glatiramer acetate in clinically isolated syndrome or early relapsing-remitting multiple sclerosis; uses o…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Climate Influence on Physiotherapy in Multiple Sclerosis [NA]
A completed clinical trial evaluating whether climate conditions influence the outcomes of physiotherapy in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Biogen-sponsored clinical trial has completed comparing Avonex and Rebif to determine if they work comparably in relapsing multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Levetiracetam in Central Pain in Multiple Sclerosis(MS) [Phase 4]
A Phase 4 clinical trial evaluating levetiracetam for central pain in people with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: FOCUS Fatigue Outcome in Copaxone USers [Phase 4]
A Phase 4 clinical trial update reports on fatigue outcomes in people with multiple sclerosis treated with Copaxone.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis [Phase 2]
Phase 2 safety and efficacy study of CNTO1275 in patients with multiple sclerosis has completed, with results posted. The sponsor was Centoc…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
An update on an exploratory study evaluating the reparative and regenerative potential of alemtuzumab in relapsing-remitting multiple sclero…
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: BEYOND Pilot Study [Phase 2]
The BEYOND Pilot Study, a Phase 2 trial sponsored by Bayer, has completed in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS) [EARLY_Phase 1]
A multicenter early-phase study assessed whether plasma exchange can accelerate natalizumab clearance in people with relapsing forms of mult…
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose [Phase 3]
Phase 3 trial update reporting Betaferon/Betaseron efficacy outcomes at a new dose for relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Natalizumab High Titer Immunogenicity and Safety [Phase 2]
Phase 2 study of natalizumab in multiple sclerosis reports on high-titer immunogenicity and related safety findings. Results were posted in …